User profiles for F. C. Hamdy
Freddie HamdyNuffield Professor of Surgery, University of Oxford Verified email at nds.ox.ac.uk Cited by 44277 |
Prevention and early detection of prostate cancer
Prostate cancer is a common malignancy in men and the worldwide burden of this disease is
rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer …
rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer …
MicroRNA in prostate, bladder, and kidney cancer: a systematic review
CONTEXT: MicroRNAs (miRNA) are noncoding RNAs that post-transcriptionally regulate
gene expression. Their altered expression and function have been observed in most urologic …
gene expression. Their altered expression and function have been observed in most urologic …
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis
OBJECTIVE:: Measurement of serum prostate-specific antigen (PSA) for the detection of
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has been …
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has been …
[HTML][HTML] 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background The comparative effectiveness of treatments for prostate cancer that is detected
by prostate-specific antigen (PSA) testing remains uncertain. Methods We compared active …
by prostate-specific antigen (PSA) testing remains uncertain. Methods We compared active …
[HTML][HTML] Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2023 - Mass Medical Soc
… Hamdy can be contacted at freddie . hamdy@ nds . ox . ac . … Hamdy and Bryant are
supported by the Oxford NIHR Biomedical Research Centre, Surgical Innovation and Evaluation …
supported by the Oxford NIHR Biomedical Research Centre, Surgical Innovation and Evaluation …
[HTML][HTML] Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
JL Donovan, FC Hamdy, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background Robust data on patient-reported outcome measures comparing treatments for
clinically localized prostate cancer are lacking. We investigated the effects of active monitoring…
clinically localized prostate cancer are lacking. We investigated the effects of active monitoring…
Multiple newly identified loci associated with prostate cancer susceptibility
Prostate cancer is the most common cancer affecting males in developed countries. It shows
consistent evidence of familial aggregation, but the causes of this aggregation are mostly …
consistent evidence of familial aggregation, but the causes of this aggregation are mostly …
[HTML][HTML] Changes in circulating microRNA levels associated with prostate cancer
…, B Rhees, C Kuslich, T Visakorpi, FC Hamdy - British journal of …, 2012 - nature.com
Background: The aim of this study was to investigate the hypothesis that changes in circulating
microRNAs (miRs) represent potentially useful biomarkers for the diagnosis, staging and …
microRNAs (miRs) represent potentially useful biomarkers for the diagnosis, staging and …
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
…, EM Grindedal, DE Neal, JL Donovan, FC Hamdy… - Nature …, 2018 - nature.com
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Prostate cancer is the most frequently diagnosed cancer in males in developed countries.
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …